Literature DB >> 23715939

Multidisciplinary approach for HCC patients: hepatology for the oncologists.

C Barone1, D Koeberle, H Metselaar, G Parisi, D Sansonno, G Spinzi.   

Abstract

Hepatocellular carcinoma (HCC) is a complex and heterogeneous disease, often associated with underlying conditions, like cirrhosis or other relevant co-morbidities that worsen the prognosis and make the clinical management more challenging. Current recommendations emphasize the importance of a multidisciplinary approach for the management of HCC patients and stress the crucial role of careful prevention and the management of cirrhosis-associated complications. This article discusses the importance of a multidisciplinary approach in the treatment of HCC patients. Current recommendations for the treatment of cirrhotic patients with HCC are also reviewed.

Entities:  

Keywords:  cirrhosis; hepatocellular carcinoma; multidisciplinary approach

Mesh:

Year:  2013        PMID: 23715939     DOI: 10.1093/annonc/mdt053

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  12 in total

1.  MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27.

Authors:  Yue-Feng Yang; Fei Wang; Jun-Jie Xiao; Yang Song; Ying-Ying Zhao; Yan Cao; Yi-Hua Bei; Chang-Qing Yang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 2.  Multidisciplinary Approach to HCC Management: How Can This Be Done?

Authors:  Melissa M Gadsden; David E Kaplan
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

Review 3.  Recent advances in multidisciplinary management of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Imam Waked
Journal:  World J Hepatol       Date:  2015-04-08

4.  Establishment of a Regional Virtual Tumor Board Program to Improve the Process of Care for Patients With Hepatocellular Carcinoma.

Authors:  Aitua C Salami; Gala M Barden; Diana L Castillo; Mina Hanna; Nancy J Petersen; Jessica A Davila; Aanand D Naik; Daniel A Anaya
Journal:  J Oncol Pract       Date:  2014-12-02       Impact factor: 3.840

Review 5.  Liver transplantation for hepatobiliary malignancies: a new era of "Transplant Oncology" has begun.

Authors:  Taizo Hibi; Osamu Itano; Masahiro Shinoda; Yuko Kitagawa
Journal:  Surg Today       Date:  2016-04-29       Impact factor: 2.549

Review 6.  Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine.

Authors:  Taizo Hibi; Masahiro Shinoda; Osamu Itano; Yuko Kitagawa
Journal:  Organogenesis       Date:  2014-05-16       Impact factor: 2.500

7.  How admissions to various medical specialty divisions determines the outcome of patients with hepatocellular carcinoma: results from a retrospective study in a large hospital of northwest China.

Authors:  Qianqian Zhu; Na Li; Fang Li; Zhihua Zhou; Jiao Sang; Xiaoyan Zeng; Qunying Han; Yi Lv; Wenxuan Zhao; Zhengwen Liu
Journal:  Ther Clin Risk Manag       Date:  2017-04-18       Impact factor: 2.423

Review 8.  The importance of a multidisciplinary approach to hepatocellular carcinoma.

Authors:  Osama Siddique; Eric R Yoo; Ryan B Perumpail; Brandon J Perumpail; Andy Liu; George Cholankeril; Aijaz Ahmed
Journal:  J Multidiscip Healthc       Date:  2017-03-20

Review 9.  Role of estrogen in hepatocellular carcinoma: is inflammation the key?

Authors:  Liang Shi; Yili Feng; Hui Lin; Rui Ma; Xiujun Cai
Journal:  J Transl Med       Date:  2014-04-08       Impact factor: 5.531

Review 10.  Hepatocellular carcinoma: early-stage management challenges.

Authors:  Derek J Erstad; Kenneth K Tanabe
Journal:  J Hepatocell Carcinoma       Date:  2017-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.